• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Kirk McDonald Appointed to Ziff Davis Board of Directors

    11/16/23 4:35:00 PM ET
    $ELAN
    $ZD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Telecommunications Equipment
    Telecommunications
    Get the next $ELAN alert in real time by email

    Ziff Davis, Inc. (NASDAQ:ZD), today announced the appointment of Kirk McDonald to its Board of Directors, effective November 15, 2023. McDonald is a highly accomplished executive with extensive experience and a career spanning more than three decades in media, technology, and advertising.

    "We are thrilled to welcome Kirk to our Board of Directors," said Ziff Davis Board Chair Sarah Fay. "As an industry veteran known for his business leadership, he will be an asset to Ziff Davis."

    McDonald serves as CEO of GroupM North America, a leading media investment agency. He announced that he will leave the role at year end. Prior to this, he was Chief Business Officer of Warner Media's Xandr when it was a division of AT&T. He was also President of Pubmatic, and has held executive level leadership roles at Time Inc., the Aquantive division of Microsoft, and CNET Networks. McDonald currently serves on the board of Elanco (NYSE:ELAN), and is a founding member of the Black Executive CMO Alliance. He also serves on the boards of directors of industry organizations including the Ad Council (as co-chair), the Paley Center for Media, and the Advertising Week Advisory Council. An alumnus of the City College of New York, Mr. McDonald majored in English as an undergraduate.

    "Kirk is widely respected in our industry, and has been a leader and innovator across a range of companies in the media and advertising ecosystem," said Ziff Davis CEO Vivek Shah.

    "I am delighted to be joining the Ziff Davis Board of Directors," McDonald said. "I look forward to working with Vivek and the entire Ziff Davis team across its portfolio of leading brands."

    About Ziff Davis

    Ziff Davis (NASDAQ:ZD) is a vertically focused digital media and internet company whose portfolio includes leading brands in technology, shopping, gaming and entertainment, connectivity, health, cybersecurity, and martech. For more information, visit www.ziffdavis.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231116449936/en/

    Get the next $ELAN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ELAN
    $ZD

    CompanyDatePrice TargetRatingAnalyst
    Elanco Animal Health Incorporated
    $ELAN
    7/17/2025$18.00Market Perform → Outperform
    Leerink Partners
    Elanco Animal Health Incorporated
    $ELAN
    6/26/2025Mkt Perform → Outperform
    William Blair
    Ziff Davis Inc.
    $ZD
    4/22/2025$33.00Overweight → Neutral
    Analyst
    Elanco Animal Health Incorporated
    $ELAN
    12/9/2024$18.00Buy
    UBS
    Elanco Animal Health Incorporated
    $ELAN
    12/2/2024$14.00Market Perform
    Leerink Partners
    Elanco Animal Health Incorporated
    $ELAN
    9/19/2024$17.00 → $15.00Overweight → Equal-Weight
    Morgan Stanley
    Ziff Davis Inc.
    $ZD
    5/2/2024$70.00Neutral → Overweight
    JP Morgan
    Elanco Animal Health Incorporated
    $ELAN
    1/5/2024$13.00 → $20.00Hold → Buy
    Stifel
    More analyst ratings

    $ELAN
    $ZD
    SEC Filings

    View All

    SEC Form 144 filed by Elanco Animal Health Incorporated

    144 - Elanco Animal Health Inc (0001739104) (Subject)

    8/11/25 3:58:15 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Ziff Davis Inc.

    10-Q - ZIFF DAVIS, INC. (0001084048) (Filer)

    8/7/25 4:18:26 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    SEC Form 10-Q filed by Elanco Animal Health Incorporated

    10-Q - Elanco Animal Health Inc (0001739104) (Filer)

    8/7/25 9:05:13 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ziff Davis to Participate in One Investor Conference in September

    Ziff Davis, Inc. (NASDAQ:ZD), today announced its participation in one investor conference in September. Details of the conference are as follows: Citi's 2025 Global TMT Conference Location: New York Hilton Midtown, New York, NY Date and time: September 3, 2025, 4:10 pm (ET) Webcast: https://kvgo.com/citi/ziff-davis-inc-september-2025 About Ziff Davis Ziff Davis (NASDAQ:ZD) is a vertically focused digital media and internet company whose portfolio includes leading brands in technology, shopping, gaming and entertainment, health and wellness, connectivity, cybersecurity, and martech. For more information, visit www.ziffdavis.com. View source version on businesswire.com: https:

    8/14/25 7:00:00 AM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Elanco Animal Health Reports Second Quarter 2025 Results

    Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target Second Quarter 2025 Financial Results:Revenue of $1,241 million, an increase of 5% year-over-year; 8% organic constant currency growthReported Net Income of $11 million, Adjusted Net Income of $131 millionAdjusted EBITDA of $238 million; Adjusted EBITDA Margin of 19.2% Reported EPS of $0.02, Adjusted EPS of $0.26Net leverage ratio of 4.0x Adjusted EBITDAFull Year 2025 Guidance:Raising revenue guidance to $4,570 to $4,620 million; expect accelerating organic constant currency revenue growth of 5% to 6% vs. 3% in 2024Raising 2025 innovation revenue target by $60 million to $720 to $800 millionReported

    8/7/25 6:27:00 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ziff Davis Reports Second Quarter 2025 Financial Results and Reaffirms 2025 Guidance

    Ziff Davis, Inc. (NASDAQ:ZD) ("Ziff Davis" or "the Company") today reported unaudited financial results for the second quarter ended June 30, 2025. "We are very pleased with our second quarter results, which exceeded expectations and marked our strongest quarterly revenue growth since 2021," said Vivek Shah, Chief Executive Officer of Ziff Davis. "Our new segment reporting is providing greater transparency into the intrinsic value of our key businesses, including breakthrough results from our Connectivity and Health & Wellness businesses." SECOND QUARTER 2025 RESULTS Q2 2025 quarterly revenues increased 9.8% to $352.2 million compared to $320.8 million for Q2 2024. Income from op

    8/6/25 6:00:00 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    $ELAN
    $ZD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kurzius Lawrence Erik bought $211,000 worth of shares (20,000 units at $10.55), increasing direct ownership by 22% to 111,459 units (SEC Form 4)

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    3/11/25 5:13:30 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Hoover R David bought $272,558 worth of shares (25,000 units at $10.90) (SEC Form 4)

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    3/7/25 4:21:21 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Kretzmer W Brian bought $25,029 worth of Common Stock $0.01 Par Value (653 units at $38.33), increasing direct ownership by 5% to 12,968 units (SEC Form 4)

    4 - ZIFF DAVIS, INC. (0001084048) (Issuer)

    3/6/25 6:01:33 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    $ELAN
    $ZD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Elanco Animal Health upgraded by Leerink Partners with a new price target

    Leerink Partners upgraded Elanco Animal Health from Market Perform to Outperform and set a new price target of $18.00

    7/17/25 7:51:30 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Elanco Animal Health upgraded by William Blair

    William Blair upgraded Elanco Animal Health from Mkt Perform to Outperform

    6/26/25 7:49:03 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ziff Davis downgraded by Analyst with a new price target

    Analyst downgraded Ziff Davis from Overweight to Neutral and set a new price target of $33.00

    4/22/25 7:23:44 AM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    $ELAN
    $ZD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    8/12/25 5:55:46 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Officer Modi Rajeev A.

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    8/12/25 5:54:06 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    7/29/25 4:24:55 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    Financials

    Live finance-specific insights

    View All

    Elanco Animal Health Reports Second Quarter 2025 Results

    Raising Full Year Outlook and Innovation Target, Improving Year-End Net Leverage Ratio Target Second Quarter 2025 Financial Results:Revenue of $1,241 million, an increase of 5% year-over-year; 8% organic constant currency growthReported Net Income of $11 million, Adjusted Net Income of $131 millionAdjusted EBITDA of $238 million; Adjusted EBITDA Margin of 19.2% Reported EPS of $0.02, Adjusted EPS of $0.26Net leverage ratio of 4.0x Adjusted EBITDAFull Year 2025 Guidance:Raising revenue guidance to $4,570 to $4,620 million; expect accelerating organic constant currency revenue growth of 5% to 6% vs. 3% in 2024Raising 2025 innovation revenue target by $60 million to $720 to $800 millionReported

    8/7/25 6:27:00 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ziff Davis Reports Second Quarter 2025 Financial Results and Reaffirms 2025 Guidance

    Ziff Davis, Inc. (NASDAQ:ZD) ("Ziff Davis" or "the Company") today reported unaudited financial results for the second quarter ended June 30, 2025. "We are very pleased with our second quarter results, which exceeded expectations and marked our strongest quarterly revenue growth since 2021," said Vivek Shah, Chief Executive Officer of Ziff Davis. "Our new segment reporting is providing greater transparency into the intrinsic value of our key businesses, including breakthrough results from our Connectivity and Health & Wellness businesses." SECOND QUARTER 2025 RESULTS Q2 2025 quarterly revenues increased 9.8% to $352.2 million compared to $320.8 million for Q2 2024. Income from op

    8/6/25 6:00:00 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement

    GREENFIELD, Ind., July 10, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will announce its second quarter 2025 financial results on Thursday, August 7, 2025. Elanco will also conduct a conference call on that day with the investment community and media to provide further details about the company's performance. The conference call will begin at 8:00 a.m. Eastern time. Investors, media, and the general public can access a live webcast of the conference call through the link posted on Elanco's website at https://investor.elanco.com/events-and-presentations/d

    7/10/25 8:00:00 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    Leadership Updates

    Live Leadership Updates

    View All

    Ziff Davis to Announce Second Quarter 2025 Earnings

    Ziff Davis, Inc. (NASDAQ:ZD) will release its Second Quarter 2025 Earnings at 6:00PM ET on Wednesday, August 6, 2025. Additionally, Ziff Davis invites the public, members of the press, the financial community, stockholders, and other interested parties to listen to a live audio Webcast of its Second Quarter 2025 Earnings Call at 8:30AM ET on Thursday, August 7, 2025. Vivek Shah, Chief Executive Officer, and Bret Richter, Chief Financial Officer, will host the call. Materials presented during the call will be posted on the Company's web site at ziffdavis.com and furnished as an exhibit to the Company's 8-K filed with the Securities and Exchange Commission pursuant to Regulation FD in conne

    7/16/25 7:00:00 AM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief

    The first-of-its-kind report includes results from multiple surveys revealing just how badly dogs around the country are itching for relief.Data reveals that nearly 9 in 10 dogs in the U.S. are "itchy dogs" according to their pet owners, having experienced symptoms of itchiness at some point in the year.1Allergy season makes itch worse, with 83% of pet owners saying that increased pollen levels affect their dog's itch.1Veterinarians are the most trusted ally in solving dogs' itch, and the majority of veterinarians say that itchiness is the most frustrating issue they deal with.1Leading veterinarians and canine dermatologists, including Drs. Joya Griffin, Andrew Rosenberg, and Tom Lewis, are

    6/5/25 7:45:00 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer

    GREENFIELD, Ind., May 28, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today announced the appointment of Robert VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025. VanHimbergen's appointment follows an extensive and competitive search as part of the company's commitment to long-term, sustained value creation. VanHimbergen succeeds Todd Young, who will remain with the company as an advisor through August 31, 2025, to facilitate a smooth transition. VanHimbergen currently serves as the Senior Vice President and Chi

    5/28/25 7:25:00 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ziff Davis Inc.

    SC 13G/A - ZIFF DAVIS, INC. (0001084048) (Subject)

    11/12/24 5:57:23 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by Ziff Davis Inc.

    SC 13G/A - ZIFF DAVIS, INC. (0001084048) (Subject)

    11/4/24 2:15:05 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    SEC Form SC 13G filed by Ziff Davis Inc.

    SC 13G - ZIFF DAVIS, INC. (0001084048) (Subject)

    10/31/24 11:55:01 AM ET
    $ZD
    Telecommunications Equipment
    Telecommunications